TY - JOUR
T1 - Mandibular advancement device therapy for obstructive sleep apnea
T2 - A longitudinal study among patients treated in community dental care in Finland–Potential for the precision medicine approach
AU - Vuorjoki-Ranta, Tiina Riitta
AU - Kämppi, Antti
AU - Aarab, Ghizlane
AU - Tuomilehto, Henri
AU - Pihakari, Antti
AU - Lobbezoo, Frank
AU - Ahlberg, Jari
N1 - Publisher Copyright:
© 2020, © 2020 Taylor & Francis Group, LLC.
PY - 2022
Y1 - 2022
N2 - Objective: Obstructive sleep apnea (OSA) is an increasing health problem worldwide. The aim was to evaluate long-term mandibular advancement device (MAD) therapy outcomes in community dental care among OSA patients in Finland. Methods: In all, 142 (77.2%) respondents of a questionnaire, with recently initiated treatment, were included in the study in 2010. Follow-up questionnaires were mailed in 2012 and 2017. Results: Problems occurred with the device long-term. Orofacial pain was reported more often in 2012 than in 2010 (p < 0.01). Snoring (p < 0.01) and tiredness (p < 0.05) were also significantly increased. In 2017, 50 subjects were still continuing with MAD, 20 of them as a single treatment modality. Treatment modalities in combination with MAD were CPAP, nutrition counseling, and position treatment. Discussion: Long-term MAD treatment may lead to a changing treatment-mix and set-backs. This may not only be a treatment adherence issue but also a lack of precision medicine approach regarding OSA.
AB - Objective: Obstructive sleep apnea (OSA) is an increasing health problem worldwide. The aim was to evaluate long-term mandibular advancement device (MAD) therapy outcomes in community dental care among OSA patients in Finland. Methods: In all, 142 (77.2%) respondents of a questionnaire, with recently initiated treatment, were included in the study in 2010. Follow-up questionnaires were mailed in 2012 and 2017. Results: Problems occurred with the device long-term. Orofacial pain was reported more often in 2012 than in 2010 (p < 0.01). Snoring (p < 0.01) and tiredness (p < 0.05) were also significantly increased. In 2017, 50 subjects were still continuing with MAD, 20 of them as a single treatment modality. Treatment modalities in combination with MAD were CPAP, nutrition counseling, and position treatment. Discussion: Long-term MAD treatment may lead to a changing treatment-mix and set-backs. This may not only be a treatment adherence issue but also a lack of precision medicine approach regarding OSA.
KW - Community dental care
KW - compliance
KW - follow-up studies
KW - mandibular advancement device
KW - obstructive sleep apnea
KW - snoring
UR - http://www.scopus.com/inward/record.url?scp=85083668355&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083668355&partnerID=8YFLogxK
U2 - 10.1080/08869634.2020.1752431
DO - 10.1080/08869634.2020.1752431
M3 - Article
AN - SCOPUS:85083668355
SN - 0886-9634
VL - 40
SP - 268
EP - 273
JO - Cranio - Journal of Craniomandibular and Sleep Practice
JF - Cranio - Journal of Craniomandibular and Sleep Practice
IS - 3
ER -
